Hologic, Inc [HOLX] stock is trading at $62.50, up 0.68%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The HOLX shares have lost -1.12% over the last week, with a monthly amount drifted -12.69%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Hologic, Inc [NASDAQ: HOLX] stock has seen the most recent analyst activity on March 03, 2025, when Argus downgraded its rating to a Hold. Previously, Leerink Partners downgraded its rating to Market Perform on February 06, 2025, and dropped its price target to $75. On February 03, 2025, downgrade downgraded it’s rating to Hold. Wolfe Research started tracking the stock assigning a Peer Perform rating. Needham reiterated its recommendation of a Buy but $90 remained the price target by the analyst firm on December 10, 2024. Jefferies started tracking with a Hold rating for this stock on December 10, 2024, and assigned it a price target of $85. In a note dated October 01, 2024, Citigroup downgraded an Neutral rating on this stock and revised its target price from $95 to $85.
Hologic, Inc [HOLX] stock has fluctuated between $61.70 and $84.67 over the past year. Currently, Wall Street analysts expect the stock to reach $86 within the next 12 months. Hologic, Inc [NASDAQ: HOLX] shares were valued at $62.50 at the most recent close of the market. An investor can expect a potential return of 37.6% based on the average HOLX price forecast.
Analyzing the HOLX fundamentals
Hologic, Inc [NASDAQ:HOLX] reported sales of 4.04B for the trailing twelve months, which represents a growth of 0.86%. Gross Profit Margin for this corporation currently stands at 0.56% with Operating Profit Margin at 0.24%, Pretax Profit Margin comes in at 0.23%, and Net Profit Margin reading is 0.18%. To continue investigating profitability, this company’s Return on Assets is posted at 0.09, Equity is 0.15 and Total Capital is 0.13. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 61.84 points at the first support level, and at 61.19 for the second support level. However, for the 1st resistance point, the stock is sitting at 63.01, and for the 2nd resistance point, it is at 63.53.
Ratios To Look Out For
For context, Hologic, Inc’s Current Ratio is 3.49. Also, the Quick Ratio is 2.78, while the Cash Ratio stands at 1.78. Considering the valuation of this stock, the price to sales ratio is 3.47, the price to book ratio is 2.95 and price to earnings (TTM) ratio is 19.77.
Transactions by insiders
Recent insider trading involved Mitchell Essex D, Chief Operating Officer, that happened on Dec 04 ’24 when 24856.0 shares were sold. Officer, Mitchell Essex D completed a deal on Dec 04 ’24 to buy 24856.0 shares. Meanwhile, Chief Financial Officer Oberton Karleen Marie sold 52679.0 shares on Aug 29 ’24.
